Trial intelligence / Profile preview

Prophylactic hydrocortisone for post-dural puncture headache after spinal anesthesia

IRCT201504067313N3Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of hydrocortisone in post-dural puncture headache (PDPH) (2 arms), sponsored by Tabriz University of Medical Sciences. Started Jun 2015; status: completed.

02

Drugs

hydrocortisone
03

Conditions

post-dural puncture headache (PDPH)

Beyond the preview

Go deeper on IRCT201504067313N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201504067313N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call